Thanks to your generous support, at the end of last year Curebound announced funding for three Cure Prizes including a novel approach to treating pancreatic cancer led by Andrew Lowy, MD, PhD and his collaborators at UC San Diego and Salk Institute. This exciting research is advancing toward its first clinical trial.